Skeletal muscle quality predicts overall survival in advanced liver hepatocellular carcinoma treated with SIRT and sorafenib: A subanalysis of the SORAMIC trial.
Surov A, Wienke A, Borggrefe J, Hinnerichs M, Seidensticker R, Öcal O, Schütte K, Zech CJ, Loewe C, van Delden O, Vandecaveye V, Verslype C, Gebauer B, Sengel C, Bargellini I, Iezzi R, Malfertheiner P, Berg T, Klümpen HJ, Benckert J, Gasbarrini A, Amthauer H, Sangro B, Ricke J, Seidensticker M.
Surov A, et al. Among authors: ocal o.
United European Gastroenterol J. 2024 Oct;12(8):1016-1027. doi: 10.1002/ueg2.12627. Epub 2024 Jul 15.
United European Gastroenterol J. 2024.
PMID: 39007783
Free PMC article.
Clinical Trial.